dc.contributor.author | Fotopoulos, George | en |
dc.contributor.author | Goussia, Anna | en |
dc.contributor.author | Bareta, E. | en |
dc.contributor.author | Koumpis, E. | en |
dc.contributor.author | Chrisafi, S. | en |
dc.contributor.author | Bobos, M. | en |
dc.contributor.author | Malamou-Mitsi, Vassiliki D. | en |
dc.contributor.author | Fountzilas, George | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Pentheroudakis, George | en |
dc.creator | Fotopoulos, George | en |
dc.creator | Goussia, Anna | en |
dc.creator | Bareta, E. | en |
dc.creator | Koumpis, E. | en |
dc.creator | Chrisafi, S. | en |
dc.creator | Bobos, M. | en |
dc.creator | Malamou-Mitsi, Vassiliki D. | en |
dc.creator | Fountzilas, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Pentheroudakis, George | en |
dc.date.accessioned | 2018-06-22T09:53:03Z | |
dc.date.available | 2018-06-22T09:53:03Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41633 | |
dc.description.abstract | Background: Cancer of unknown primary (CUP) possesses distinct biology and peculiar natural history, in which the roles of the winged and hedgehog signalling pathways are unclear. Materials and methods: We constructed tissue microarrays and studied the immunohistochemical (IHC) expression of β-catenin, smoothened (SMO) and the transcription factors TCF, LEF, GLI1 in 87 CUP cases for prognostic significance. Results: A low rate of IHC expression of proteins was seen, the cut-off used being any expression in ≥ 1% of tumour cells. At univariate analysis, only nuclear IHC SMO expression displayed a statistically significant association with favourable outcome [median Overall survival (OS) of 19 months in SMO-positive vs. 12 months in SMO-negative cases, P = 0·01]. An activated Wnt pathway, defined as IHC expression of any of nuclear β-catenin, TCF and LEF, was significantly associated with favourable progression free survival (median 9 vs. 5 months, P = 0·037) and OS (median 19 vs. 13 months, P = 0·04). This prognostic impact on OS was mainly driven by nuclear expression of TCF and/or LEF (P = 0·03). No prognostic significance of the hedgehog pathway activation status, defined as IHC expression of SMO or nuclear GLI1, could be established. A favourable prognostic impact of the concurrent activation of both pathways was observed. A trend for association of activated Wnt with response to chemotherapy (responders 67% among activated Wnt cases vs. 35% among nonactivated Wnt cases, P = 0·07) was observed in CUP adenocarcinomas. Conclusions: Activation of the Wnt pathway was a positive prognostic factor in a small CUP series, possibly via enhanced chemosensitivity. Independent validation is warranted. © 2015 Stichting European Society for Clinical Investigation Journal Foundation. | en |
dc.language.iso | eng | en |
dc.source | European journal of clinical investigation | en |
dc.subject | Cancer chemotherapy | en |
dc.subject | Human | en |
dc.subject | Neoplasms | en |
dc.subject | 80 and over | en |
dc.subject | Aged | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Female | en |
dc.subject | Major clinical study | en |
dc.subject | Cancer survival | en |
dc.subject | Follow up | en |
dc.subject | Priority journal | en |
dc.subject | Prognosis | en |
dc.subject | Retrospective studies | en |
dc.subject | Retrospective study | en |
dc.subject | Human tissue | en |
dc.subject | Overall survival | en |
dc.subject | Cancer prognosis | en |
dc.subject | Carcinoma | en |
dc.subject | Male | en |
dc.subject | Mortality | en |
dc.subject | Protein expression | en |
dc.subject | Immunohistochemistry | en |
dc.subject | Receptors | en |
dc.subject | Survival time | en |
dc.subject | Treatment response | en |
dc.subject | Article | en |
dc.subject | Middle aged | en |
dc.subject | Adenocarcinoma | en |
dc.subject | Squamous cell | en |
dc.subject | Squamous cell carcinoma | en |
dc.subject | Cancer of unknown primary site | en |
dc.subject | Unknown primary | en |
dc.subject | Metabolism | en |
dc.subject | Neuroendocrine tumor | en |
dc.subject | Cancer of unknown primary | en |
dc.subject | Beta catenin | en |
dc.subject | Carcinomatous peritonitis | en |
dc.subject | G protein coupled receptor | en |
dc.subject | G-protein-coupled | en |
dc.subject | Gli1 protein | en |
dc.subject | Hedgehog | en |
dc.subject | Hedgehog proteins | en |
dc.subject | Lymphoid enhancer factor 1 | en |
dc.subject | Lymphoid enhancer-binding factor 1 | en |
dc.subject | Neuroendocrine tumors | en |
dc.subject | Prognostic | en |
dc.subject | Progression free survival | en |
dc.subject | Smo protein | en |
dc.subject | Smoothened protein | en |
dc.subject | Sonic hedgehog protein | en |
dc.subject | Squamous epithelium | en |
dc.subject | T cell factor protein | en |
dc.subject | Tcf transcription factors | en |
dc.subject | Tissue array analysis | en |
dc.subject | Tissue microarray | en |
dc.subject | Transcription factor | en |
dc.subject | Transcription factor gli1 | en |
dc.subject | Transcription factors | en |
dc.subject | Very elderly | en |
dc.subject | Wingless | en |
dc.subject | Wnt pathway | en |
dc.subject | Wnt protein | en |
dc.subject | Wnt signaling pathway | en |
dc.title | Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary | en |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | 10.1111/eci.12518 | |
dc.description.volume | 45 | |
dc.description.issue | 11 | |
dc.description.startingpage | 1145 | |
dc.description.endingpage | 1152 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Pentheroudakis, George [0000-0002-6632-2462] | |
dc.contributor.orcid | Fotopoulos, George [0000-0001-7393-4080] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-6632-2462 | |
dc.gnosis.orcid | 0000-0001-7393-4080 | |